{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:43:47Z","timestamp":1791924227095,"version":"4.3.4"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.blre.2024.101219","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T16:36:48Z","timestamp":1717691808000},"page":"101219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Gut microbiome composition and dysbiosis in immune thrombocytopenia: A review of literature"],"prefix":"10.1016","volume":"67","author":[{"given":"Najmaldin","family":"Saki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakimeh","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Keikhaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryush","family":"Purrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2024.101219_bb0005","series-title":"Immune thrombocytopenia in adults: modern approaches to diagnosis and treatment. Seminars in thrombosis and hemostasis","author":"Al-Samkari","year":"2020"},{"key":"10.1016\/j.blre.2024.101219_bb0010","first-page":"76","article-title":"Recent advances in the mechanisms and treatment of immune thrombocytopenia","author":"Provan","year":"2022","journal-title":"EBioMedicine."},{"issue":"6","key":"10.1016\/j.blre.2024.101219_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MOH.0000000000000612","article-title":"An update on the pathophysiology of immune thrombocytopenia","volume":"27","author":"Semple","year":"2020","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.blre.2024.101219_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000574","article-title":"Immune thrombocytopenia: recent advances in pathogenesis and treatments","volume":"5","author":"Audia","year":"2021","journal-title":"Hemasphere."},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.blre.2024.101219_bb0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0955-3886(98)00039-3","article-title":"Virus-associated idiopathic thrombocytopenic purpura","volume":"19","author":"Rand","year":"1998","journal-title":"Transfus Sci"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.blre.2024.101219_bb0040","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2024.101219_bb0045","article-title":"Crosstalk between the intestinal virome and other components of the microbiota, and its effect on intestinal mucosal response and diseases. Journal of immunology","volume":"2022","author":"Clinton","year":"2022","journal-title":"Research."},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0050","first-page":"1","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg","year":"2020","journal-title":"Microbiome."},{"key":"10.1016\/j.blre.2024.101219_bb0055","first-page":"1","article-title":"Interaction between the gut microbiome and mucosal immune system","volume":"4","author":"Shi","year":"2017","journal-title":"Mil Med Res"},{"issue":"6","key":"10.1016\/j.blre.2024.101219_bb0060","article-title":"Microbiome in rheumatoid arthritis and celiac disease: a friend or foe","volume":"13","author":"Elsouri","year":"2021","journal-title":"Cureus."},{"key":"10.1016\/j.blre.2024.101219_bb0065","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ebiom.2019.06.031","article-title":"Microbiome and type 1 diabetes","volume":"46","author":"Siljander","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.blre.2024.101219_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.996031","article-title":"Intestinal microbiome\u2013rheumatoid arthritis crosstalk: the therapeutic role of probiotics","volume":"13","author":"Opoku","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.blre.2024.101219_bb0075","article-title":"The role of microbiome in rheumatoid arthritis treatment","volume":"11","author":"Bodkhe","year":"2019","journal-title":"Therap Adv Musculoskeletal Dis"},{"issue":"9","key":"10.1016\/j.blre.2024.101219_bb0080","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3390\/microorganisms10091820","article-title":"Bacterial compositional shifts of gut microbiomes in patients with rheumatoid arthritis in association with disease activity","volume":"10","author":"El Menofy","year":"2022","journal-title":"Microorganisms."},{"key":"10.1016\/j.blre.2024.101219_bb0085","series-title":"Microbiome\u2013host immune system interactions. Seminars in liver disease","author":"Smolinska","year":"2016"},{"issue":"7","key":"10.1016\/j.blre.2024.101219_bb0090","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen","year":"2014","journal-title":"Cell Microbiol"},{"issue":"11","key":"10.1016\/j.blre.2024.101219_bb0095","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1182\/blood-2006-12-062695","article-title":"Platelet-bound lipopolysaccharide enhances fc receptor\u2013mediated phagocytosis of IgG-opsonized platelets","volume":"109","author":"Semple","year":"2007","journal-title":"Blood"},{"issue":"7610","key":"10.1016\/j.blre.2024.101219_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature18847","article-title":"The microbiome and innate immunity","volume":"535","author":"Thaiss","year":"2016","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0105","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4049\/jimmunol.1601247","article-title":"Microbiome-modulated metabolites at the interface of host immunity","volume":"198","author":"Blacher","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2024.101219_bb0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coi.2014.07.003","article-title":"The cross talk between microbiota and the immune system: metabolites take center stage","volume":"30","author":"Shapiro","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.blre.2024.101219_bb0115","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.psj.2019.12.011","article-title":"Microbiome and pathogen interaction with the immune system","volume":"99","author":"Kogut","year":"2020","journal-title":"Poult Sci"},{"issue":"4","key":"10.1016\/j.blre.2024.101219_bb0120","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.7150\/ijbs.79430","article-title":"The role of gut microbiota in T cell immunity and immune mediated disorders","volume":"19","author":"Shim","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.blre.2024.101219_bb0125","doi-asserted-by":"crossref","first-page":"1324476","DOI":"10.3389\/frmbi.2024.1324476","article-title":"Role of pattern recognition receptors and microbiota-derived ligands in obesity","volume":"3","author":"Rolland","year":"2024","journal-title":"Front Microbiom"},{"issue":"6","key":"10.1016\/j.blre.2024.101219_bb0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.blre.2024.101219_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2016.05.008","article-title":"The expression profile of toll-like receptor signaling molecules in CD19+ B cells from patients with primary immune thrombocytopenia","volume":"176","author":"Hua","year":"2016","journal-title":"Immunol Lett"},{"key":"10.1016\/j.blre.2024.101219_bb0145","doi-asserted-by":"crossref","first-page":"100046","DOI":"10.1016\/j.bbii.2024.100046","article-title":"Influence of gut microbiota on autoimmunity: a narrative review","author":"Sai","year":"2024","journal-title":"Brain Behav Immun Integr"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0150","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2005-06-2202","article-title":"Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-\u03b1 production in vivo","volume":"107","author":"Aslam","year":"2006","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.blre.2024.101219_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30646","article-title":"Frequency of toll-like receptor 4 variants and association with treatment response in children with primary immune thrombocytopenia","volume":"70","author":"Ahmed","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2024.101219_bb0160","series-title":"T regulatory cells in human health and diseases","first-page":"191","article-title":"The association of gut microbiota and Treg dysfunction in autoimmune diseases","author":"Liu","year":"2021"},{"issue":"5","key":"10.1016\/j.blre.2024.101219_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/08916934.2017.1309034","article-title":"Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia","volume":"50","author":"Hao","year":"2017","journal-title":"Autoimmunity."},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bjh.19079","article-title":"The role of T cells and myeloid-derived suppressor cells in refractory immune thrombocytopenia","volume":"203","author":"Yazdanbakhsh","year":"2023","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0175","article-title":"Regulatory factors involved in Th17\/Treg cell balance of immune thrombocytopenia","volume":"71","author":"Kargar","year":"2023","journal-title":"Curr Res Transl Med"},{"issue":"5","key":"10.1016\/j.blre.2024.101219_bb0180","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2222.2009.03437.x","article-title":"Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models","volume":"40","author":"Lyons","year":"2010","journal-title":"Clin Exp Allergy"},{"issue":"50","key":"10.1016\/j.blre.2024.101219_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1617460113","article-title":"Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice","volume":"113","author":"Tan","year":"2016","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.blre.2024.101219_bb0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.thromres.2011.02.024","article-title":"TLR7 promotes Th1 polarization in immune thrombocytopenia","volume":"128","author":"Yang","year":"2011","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.blre.2024.101219_bb0195","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ni.3233","article-title":"Commensal bacteria direct selective cargo sorting to promote symbiosis","volume":"16","author":"Zhang","year":"2015","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.blre.2024.101219_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2017.6","article-title":"Microbiome effects on immunity, health and disease in the lung","volume":"6","author":"Shukla","year":"2017","journal-title":"Clin Transl Immunol"},{"issue":"4","key":"10.1016\/j.blre.2024.101219_bb0205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000230130","article-title":"The Normal microbial Flora as a major stimulus for proliferation of plasma cells synthesizing IgA in the GutThe germ-free intestinal tract","volume":"34","author":"Crabbe","year":"1968","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.blre.2024.101219_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/361604","article-title":"Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota","volume":"2015","author":"Carasi","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.blre.2024.101219_bb0220","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1007\/s00018-019-03190-6","article-title":"Bridging intestinal immunity and gut microbiota by metabolites","volume":"76","author":"Wang","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.blre.2024.101219_bb0225","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.blre.2024.101219_bb0230","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood-2013-11-427781","article-title":"Human innate lymphoid cells","volume":"124","author":"Hazenberg","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity."},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0240","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","article-title":"The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells","volume":"36","author":"Qiu","year":"2012","journal-title":"Immunity."},{"key":"10.1016\/j.blre.2024.101219_bb0245","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3389\/fimmu.2020.01315","article-title":"IL-10 and IL-22 in mucosal immunity: driving protection and pathology","volume":"11","author":"Wei","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28075","article-title":"Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia","volume":"67","author":"Wang","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2024.101219_bb0255","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3389\/fmicb.2020.01550","article-title":"Gut microbiome and metabolome were altered and strongly associated with platelet count in adult patients with primary immune thrombocytopenia","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.blre.2024.101219_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2023.102361","article-title":"The mycobiome: interactions with host and implications in diseases","volume":"75","author":"Fan","year":"2023","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"10.1016\/j.blre.2024.101219_bb0265","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/mi.2010.22","article-title":"IL-22 defines a novel immune pathway of antifungal resistance","volume":"3","author":"De Luca","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.blre.2024.101219_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mib.2021.04.004","article-title":"The intestinal mycobiome as a determinant of host immune and metabolic health","volume":"62","author":"Gutierrez","year":"2021","journal-title":"Curr Opin Microbiol"},{"issue":"10","key":"10.1016\/j.blre.2024.101219_bb0275","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/MCG.0000000000000404","article-title":"Immune thrombocytopenia caused by fecal microbial transplantation in a patient with severe recurrent Clostridium difficile infection","volume":"49","author":"Malnick","year":"2015","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0280","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","article-title":"Fecal microbiota transplantation and emerging applications","volume":"9","author":"Borody","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.blre.2024.101219_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.796025","article-title":"The power of microbiome studies: some considerations on which alpha and beta metrics to use and how to report results","volume":"12","author":"Kers","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.blre.2024.101219_bb0290","article-title":"Associations of gut microbiota and fatty metabolism with immune thrombocytopenia","volume":"9","author":"Yu","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0295","doi-asserted-by":"crossref","first-page":"2277501","DOI":"10.1080\/16078454.2023.2277501","article-title":"Intestinal flora altered and correlated with interleukin-2\/4 in patients with primary immune thrombocytopenia","volume":"28","author":"Wang","year":"2023","journal-title":"Hematology."},{"key":"10.1016\/j.blre.2024.101219_bb0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.thromres.2020.03.012","article-title":"Intestinal microbiota dysbiosis play a role in pathogenesis of patients with primary immune thrombocytopenia","volume":"190","author":"Liu","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2024.101219_bb0305","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s11427-020-1788-2","article-title":"Gut microbiome alterations and its link to corticosteroid resistance in immune thrombocytopenia","volume":"64","author":"Wang","year":"2021","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.blre.2024.101219_bb0310","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood-2021-154180","article-title":"Pediatric patients with immune thrombocytopenic Purpura have a Dysbiotic gut microbiome at time of diagnosis","volume":"138","author":"Oved","year":"2021","journal-title":"Blood."},{"key":"10.1016\/j.blre.2024.101219_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1190866","article-title":"Causal relationship between gut microbiota and immune thrombocytopenia: a Mendelian randomization study of two samples","volume":"14","author":"Guo","year":"2023","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.blre.2024.101219_bb0320","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/nu12051474","article-title":"The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients."},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107449","article-title":"Bacteroidetes and Firmicutes levels in gut microbiota and effects of hosts TLR2\/TLR4 gene expression levels in adult type 1 diabetes patients in Istanbul, Turkey","volume":"34","author":"Demirci","year":"2020","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.blre.2024.101219_bb0330","series-title":"Increased expression of TLR2 and TLR4 in mononuclear cells in patient with immune thrombocytopenic Purpura","author":"Cheng","year":"2007"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0335","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.thromres.2013.04.025","article-title":"Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura","volume":"132","author":"Liu","year":"2013","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.blre.2024.101219_bb0340","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/imm.13158","article-title":"Depletion of Foxp3+ regulatory T cells is accompanied by an increase in the relative abundance of Firmicutes in the murine gut microbiome","volume":"159","author":"Kehrmann","year":"2020","journal-title":"Immunology."},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0345","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","article-title":"Abnormality of CD4+ CD25+ regulatory T cells in idiopathic thrombocytopenic purpura","volume":"78","author":"Liu","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2024.101219_bb0350","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood-2018-99-113983","article-title":"Berberine may correct corticosteroid resistance induced by gut microbiota Dysbiosis in immune thrombocytopenia","volume":"132","author":"Wang","year":"2018","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0355","doi-asserted-by":"crossref","first-page":"1848158","DOI":"10.1080\/19490976.2020.1848158","article-title":"Gut Bacteroides species in health and disease","volume":"13","author":"Zafar","year":"2021","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0360","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/cei.13195","article-title":"Antigenic mimicry of ubiquitin by the gut bacterium Bacteroides fragilis: a potential link with autoimmune disease","volume":"194","author":"Stewart","year":"2018","journal-title":"Clin Exp Immunol"},{"issue":"17","key":"10.1016\/j.blre.2024.101219_bb0365","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2008-12-193664","article-title":"Molecular mimicry and immune thrombocytopenia","volume":"113","author":"Aster","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2024.101219_bb0370","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/jcm10071356","article-title":"Epidemiology and viral etiology of pediatric immune thrombocytopenia through Korean public health data analysis","volume":"10","author":"Lim","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0375","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2005-01-0243","article-title":"Role of molecular mimicry to HIV-1 peptides in HIV-1\u2013related immunologic thrombocytopenia","volume":"106","author":"Li","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.blre.2024.101219_bb0380","first-page":"1","article-title":"Gut microbiota and autoimmune diseases: mechanisms, treatment, challenges, and future recommendations","author":"Sadeghpour","year":"2024","journal-title":"Curr Clin Microbiol Rep"},{"key":"10.1016\/j.blre.2024.101219_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2023.102721","article-title":"The potential role of molecular mimicry by the anaerobic microbiota in the aetiology of autoimmune disease","volume":"80","author":"English","year":"2023","journal-title":"Anaerobe."},{"issue":"3","key":"10.1016\/j.blre.2024.101219_bb0390","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/AEM.03133-13","article-title":"Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract","volume":"80","author":"Kaci","year":"2014","journal-title":"Appl Environ Microbiol"},{"issue":"13","key":"10.1016\/j.blre.2024.101219_bb0395","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1128\/AEM.03021-10","article-title":"Inhibition of the NF-\u03baB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius","volume":"77","author":"Kaci","year":"2011","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0400","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/jcm.30.1.243-244.1992","article-title":"Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections","volume":"30","author":"Whiley","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2024.101219_bb0405","series-title":"Lactobacillus: host\u2013microbe relationships. Between pathogenicity and commensalism","first-page":"119","author":"O\u2019Callaghan","year":"2011"},{"issue":"12","key":"10.1016\/j.blre.2024.101219_bb0410","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2021-220687","article-title":"Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese","volume":"80","author":"Tomofuji","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.blre.2024.101219_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199018","article-title":"Orally administered heat-killed Lactobacillus paracasei MCC1849 enhances antigen-specific IgA secretion and induces follicular helper T cells in mice","volume":"13","author":"Arai","year":"2018","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.blre.2024.101219_bb0420","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol"},{"issue":"4","key":"10.1016\/j.blre.2024.101219_bb0425","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrgastro.2012.14","article-title":"IBD\u2014what role do Proteobacteria play?","volume":"9","author":"Mukhopadhya","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.blre.2024.101219_bb0430","series-title":"Role of microorganisms in pathogenesis and management of autoimmune diseases: Volume II: Kidney, central nervous system, eye, blood, blood vessels & bowel","first-page":"373","article-title":"Microorganisms in the pathogenesis and management of Immune Thrombocytopenia (ITP)","author":"G\u0103man","year":"2023"},{"key":"10.1016\/j.blre.2024.101219_bb0435","article-title":"Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: a population-matched retrospective cohort study","volume":"102997","author":"Lee","year":"2023","journal-title":"J Autoimmun"},{"issue":"16","key":"10.1016\/j.blre.2024.101219_bb0440","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.3390\/jcm11164822","article-title":"Helicobacter pylori infection and chronic immune thrombocytopenia","volume":"11","author":"Takeuchi","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0445","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2141.2003.04735.x","article-title":"Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura","volume":"124","author":"Takahashi","year":"2004","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2024.101219_bb0450","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.immuni.2014.03.005","article-title":"Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation","volume":"40","author":"Goto","year":"2014","journal-title":"Immunity."},{"issue":"5\u20136","key":"10.1016\/j.blre.2024.101219_bb0455","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/08830185.2013.839665","article-title":"The effect of probiotics and gut microbiota on Th17 cells","volume":"32","author":"Tanabe","year":"2013","journal-title":"Int Rev Immunol"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0460","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1586\/ehm.12.7","article-title":"Risk and prognosis of adult primary immune thrombocytopenia","volume":"5","author":"Frederiksen","year":"2012","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0465","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/jcm8020230","article-title":"The relationship between platelet count and host gut microbiota: a population-based retrospective cross-sectional study","volume":"8","author":"Yoon","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.blre.2024.101219_bb0470","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fcimb.2023.1168756","article-title":"Gut microbiota were altered with platelet count and red blood cell count in immune thrombocytopenia patients with different treatments","volume":"13","author":"Rui","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.blre.2024.101219_bb0475","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1128\/iai.56.7.1673-1677.1988","article-title":"Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases","volume":"56","author":"Theander","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.blre.2024.101219_bb0480","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6665563","article-title":"The gut microbiota and its relevance to peripheral lymphocyte subpopulations and cytokines in patients with rheumatoid arthritis","volume":"2021","author":"Li","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.blre.2024.101219_bb0485","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/blood-2021-148987","article-title":"Machine-learning model for resistance\/relapse prediction in immune thrombocytopenia using gut microbiota and function signatures","volume":"138","author":"Liu","year":"2021","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.blre.2024.101219_bb0490","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/ijms17030431","article-title":"Molecular insight into gut microbiota and rheumatoid arthritis","volume":"17","author":"Wu","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.blre.2024.101219_bb0495","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1128\/AEM.02676-14","article-title":"Dynamics of gut microbiota in autoimmune lupus","volume":"80","author":"Zhang","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.blre.2024.101219_bb0500","first-page":"S352","article-title":"Reversal of idiopathic thrombocytopenic purpura [ITP] with fecal microbiota transplantation [FMT]: 941","volume":"106","author":"Borody","year":"2011","journal-title":"Off J Am College Gastroenterol| ACG"},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12765","article-title":"Intestinal dysbiosis and probiotic applications in autoimmune diseases","volume":"152","author":"de Oliveira","year":"2017","journal-title":"Immunology."},{"issue":"2","key":"10.1016\/j.blre.2024.101219_bb0510","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ibd.20602","article-title":"Mechanisms of action of probiotics: recent advances","volume":"15","author":"Ng","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.blre.2024.101219_bb0515","series-title":"The human metabolome. Metabolic profiling: Its role in biomarker discovery and gene function analysis","first-page":"311","author":"Beecher","year":"2003"},{"issue":"suppl_1","key":"10.1016\/j.blre.2024.101219_bb0520","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"10.1016\/j.blre.2024.101219_bb0525","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1101\/gad.284091.116","article-title":"Metabolites: messengers between the microbiota and the immune system","volume":"30","author":"Levy","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.blre.2024.101219_bb0530","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2015.01.001","article-title":"Application of metabolomics in autoimmune diseases: insight into biomarkers and pathology","volume":"279","author":"Kang","year":"2015","journal-title":"J Neuroimmunol"},{"issue":"12","key":"10.1016\/j.blre.2024.101219_bb0535","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/metabo11120812","article-title":"Metabolomics in autoimmune diseases: focus on rheumatoid arthritis, systemic lupus erythematous, and multiple sclerosis","volume":"11","author":"Yoon","year":"2021","journal-title":"Metabolites."},{"issue":"9","key":"10.1016\/j.blre.2024.101219_bb0540","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1096\/fj.201600375R","article-title":"Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes","volume":"30","author":"Croasdell","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.blre.2024.101219_bb0545","doi-asserted-by":"crossref","DOI":"10.1111\/trf.15750","article-title":"Use of specialized pro-resolving mediators to alleviate cold platelet storage lesion","volume":"60","author":"Reddoch-Cardenas","year":"2020","journal-title":"Transfusion."},{"issue":"10","key":"10.1016\/j.blre.2024.101219_bb0550","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.blre.2024.101219_bb0555","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut."},{"issue":"12","key":"10.1016\/j.blre.2024.101219_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109726","article-title":"Gut microbiota-mediated secondary bile acids regulate dendritic cells to attenuate autoimmune uveitis through TGR5 signaling","volume":"36","author":"Hu","year":"2021","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.blre.2024.101219_bb0565","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.3390\/ijms19123755","article-title":"Functional annotation of bacterial signal transduction systems: progress and challenges","volume":"19","author":"Mart\u00edn-Mora","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.blre.2024.101219_bb0570","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOG.0b013e32835a68ea","article-title":"Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?","volume":"29","author":"Robertson","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/j.blre.2024.101219_bb0575","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","article-title":"Intracellular NOD-like receptors in host defense and disease","volume":"27","author":"Kanneganti","year":"2007","journal-title":"Immunity."},{"issue":"9","key":"10.1016\/j.blre.2024.101219_bb0580","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin\u2014a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp Mol Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X24000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X24000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T19:09:48Z","timestamp":1724526588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X24000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":116,"alternative-id":["S0268960X24000523"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2024.101219","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome composition and dysbiosis in immune thrombocytopenia: A review of literature","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2024.101219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101219"}}